Literature DB >> 2937039

[Food allergy. Objective diagnosis and test of therapeutic efficacy by measuring intestinal permeability].

C André.   

Abstract

Gastrointestinal permeability was evaluated in 90 healthy subjects and in 12 patients with food allergy by oral administration of 5 g of mannitol, a marker of small molecule absorption, and 5 g of lactulose, a marker of large molecule abnormal absorption, and measurement of mannitol and lactulose urinary excretion. In the healthy subjects the mean 5-hour urinary excretion was 14.11% for mannitol and 0.26% for lactulose. The 12 patients with food allergy showed a normal urinary recovery of mannitol (14.35%) and a slightly greater urinary recovery of lactulose (0.49%). Intestinal permeability was also studied immediately after ingestion of an offending food allergen. This challenge test resulted in decrease in mannitol recovery (12.36%) and an increase in lactulose recovery (1.80%). Oral sodium cromoglycate administered before the test protected all patients against symptoms and abnormal intestinal permeability. Measuring intestinal permeability is an objective means of diagnosing food allergy and evaluating therapeutic effectiveness.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2937039

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  3 in total

1.  Assessment of the lactulose-mannitol test in Crohn's disease.

Authors:  F Andre; C Andre; Y Emery; J Forichon; L Descos; Y Minaire
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

2.  Few food diets in the treatment of atopic eczema.

Authors:  M G Pike; C M Carter; P Boulton; M W Turner; J F Soothill; D J Atherton
Journal:  Arch Dis Child       Date:  1989-12       Impact factor: 3.791

3.  Functional and morphological changes in small bowel of Crohn's disease patients. Influence of site of disease.

Authors:  R D'Incà; G C Sturniolo; D Martines; V Di Leo; A Cecchetto; C Venturi; R Naccarato
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.